Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life [QOL] of Patients With Parkinson's Disease.

Trial Profile

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life [QOL] of Patients With Parkinson's Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Levodopa/carbidopa/entacapone (Primary) ; Levodopa/carbidopa
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms QUEST-AP-1
  • Sponsors Novartis
  • Most Recent Events

    • 23 Nov 2007 The expected completion date for this trial is now 1 Jun 2006.
    • 31 Oct 2006 Results have been reported.
    • 20 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top